View full meeting coverage »

Eyetube Meeting Coverage:

2018 World Ophthalmology Congress


Editorially Independent Content, Financially Supported by


Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

The Latest BOULEVARD Trial Results

  Channels: Retina | Posted 6/20/2018

Arshad M. Khanini, MD, presents the results of the phase 2 BOULEVARD trial, which studied the efficacy of RG7716 in patients with diabetic macular edema. RG7716 is the first bispecific antibody designed for intravitreal use.

1 / 12 Series: 2018 World Ophthalmology Congress